PR PolyResearch

Join Free

NASDAQ

Compass Therapeutics, Inc. (CMPX)

♥ 396 Thanks from members

Compass Therapeutics, Inc. (CMPX) displays positive web sentiment driven by a robust clinical pipeline, $180 million in cash runway extending into 2028, and significant analyst upside targets despite ongoing net losses.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other Nasdaq Tickers

GraniteShares 2x Long AAPL Daily ETF (AAPB)

Apple Inc. (AAPL)

Direxion Daily AAPL Bear 1X ETF (AAPD)

Ascentage Pharma Group International - American Depository Shares (AAPG)

Direxion Daily AAPL Bull 2X ETF (AAPU)

Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)